- Display 45 Products per page
Published: May 13, 2016 | Price: $1,200.00 – $2,400.00
The Global Market for Medical Devices, 7th Edition In its 7th edition, Global Market for Medical Devices outlines several trends in the world of medical devices that are continuing and some new ones as well. The report provides analysis of medical devices and their regulation and revenues in several world markets. Revenues and projections are presented to 2020, for world sales as well as revenues of the United States, China, Japan, India Brazil, Germany, Canada and other nations. Kalorama provides...Published: October 6, 2017 | Price: $3,600.00 – $5,400.00
40 Specific Medical Device Markets This report is a comprehensive view of the medical device market. As part of its coverage, the report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. The report examines specific medical device markets, describing trends and major medical device companies in many fields. The report addresses device category segment markets, analyzing these to help render the total market for medical...Published: November 28, 2018 | Price: $4,500.00 – $9,000.00
The Global Market for Medical Devices, 9th Edition (40+ Specific Device Markets and 50 Country Markets Forecasted to 2023) The ninth edition of Kalorama Information’s Global Market for Medical Devices provides a complete view of the medical device market and opportunity for medical device companies, competitors, and investors. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and those of 50 countries, a survey of regulatory practices across the world, research...Published: May 28, 2014 | Price: $995.00 – $1,990.00
Global Market for Medical Devices, 5th Edition The fifth edition of Kalorama Information’s Global Market for Medical Devices presents an industry adjusting to challenges of reimbursement reductions and new taxes. New product innovations and mergers were part of the strategies companies adapted in order to compete. In the United States, the second year of collections on the medical device tax began, and the report describes the impact. In Europe as well as the United States, reimbursement challenges and the threat...Published: May 1, 2010 | Price: $995.00 – $1,990.00
RFID offers various solutions for the main segments of the healthcare industry—hospitals and nursing homes, pharmaceutical manufacturers, distributors, and pharmacies. This Kalorama Information report, The Global Market for RFID in Healthcare , defines the market for RFID opportunities in the healthcare industry, focusing on five market segments: Pharmaceutical/Blood Product Distribution and Tracking Patient/Medical Staff Identification and Tracking Medical Asset Tracking and Locating Implantable Device RFID use Other areas (including medical documents and patient records) Market estimates and...Published: December 14, 2012 | Price: $1,995.00 – $4,000.00
Fixation systems used to speed healing of trauma injuries represent one of the growth areas of the global orthopedic devices market, with a host of competitors and continual product innovation. In the United States each year alone, trauma accounts for over 42 million emergency room visits. As the global elderly population grows, so does the incidence of falls and osteoporosis, increasing the need for orthopedic trauma devices. But it is not without its challenges. The report’s geographic scope is worldwide with...Published: August 16, 2013 | Price: $995.00 – $1,995.00
The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry The "Patient Protection and Affordable Care Act" (H.R. 3590) is complex legislation that affects virtually every aspect of health care, and many of its provisions are beginning to take effect now. IVD manufacturers who have different needs and strategies are now considering the legislation and whether it will help or hurt business plans. The legislation contains a range of different provisions and while the law in a broad sense...Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is one of the most difficult forecasting projects in market research. In this nearly 500-page analysis, Kalorama Information has compiled all the relevant information about the candidates, their value, and their...Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...Published: February 26, 2024 | Price: $5,000.00 – $10,500.00
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: September 14, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in VietnamThe IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious...Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: February 27, 2014 | Price: $995.00 – $1,990.00
The Long Term Care Market, Forecasts to 2018 The advancing age of the population makes long-term care an important consideration for health marketers. This report, The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care Home care Hospice care Assisted living ...Published: February 16, 2016 | Price: $3,360.00 – $6,370.00
The Long Term Care Market The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living examines the most important segments of the long term care business, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis. Kalorama’s 6th edition of this detailed report provides a size and projection for each market segment, including the following: overall U.S. long term care industry 2011–2020 (nursing home care, home care,...Published: March 15, 2012 | Price: $3,995.00 – $7,990.00
The advancing age of the population makes long-term care an important consideration for health marketers. This report, The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care; Home care; Hospice care; Assisted living. Kalorama Information publishes its fourth edition of this detailed report on the...Published: February 6, 2019 | Price: $5,000.00 – $10,000.00
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living This Kalorama Information report, The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living provides detailed market research on the U.S. long-term care market. This market complex and diverse industry evolves nearly every year, and influences other markets such as the sales of pharmaceuticals, devices and healthcare services. For seven editions, Kalorama has provided a look at who is leading, what the...Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: March 24, 2022 | Price: $5,000.00 – $10,000.00
The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: February 5, 2018 | Price: $3,995.00 – $8,400.00
The Market and Potential for CRISPR/Cas9 Gene Editing This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following: Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023 The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development,...Published: January 22, 2021 | Price: $4,000.00 – $8,000.00
This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...Published: January 25, 2018 | Price: $3,995.00 – $7,900.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...Published: February 22, 2019 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Molecular diagnostics performed at the point of care or near the patient is regarded as a leading expansion segment in the global in vitro diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the...Published: February 5, 2014 | Price: $2,995.00 – $5,990.00
The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products. A good number of companies are producing or...Published: February 26, 2016 | Price: $3,360.00 – $6,720.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth current sales and market opportunity and providing the following market information: Molecular POC Market for...Published: September 27, 2019 | Price: $5,000.00 – $10,000.00
Issues facing the healthcare industry are challenging and complex, including staff reductions, increased service demands and funding cuts. It is not surprising then that many are looking to the advanced solutions that artificial intelligence (AI) can offer in this realm. Kalorama Information's report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in...Published: June 19, 2015 | Price: $4,200.00 – $8,400.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) have tremendous utility in cancer research, aiding researchers in deciphering the complex processes leading to cancer metastasis and in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or imaging technologies, have numerous limitations. Although their biology and characteristics are...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...Published: August 1, 2005 | Price: $2,500.00 – $5,000.00
This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and techniques have evolved from steady improvements, including the use of antibiotic materials, biosensors, wireless communications, and more efficient pumps and controllers. These new developments have...Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...Published: January 10, 2018 | Price: $4,200.00 – $7,990.00
The Market for Direct-to-Consumer Genetic Health Testing The Market for Direct-to-Consumer Genetic Health Testing provides an overview of the laboratory testing industry for advanced genetic tests. Market trends covered include world DTC genetic testing revenues, 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing volume distribution for genetic testing services by order origination source...Published: January 1, 2016 | Price: $3,360.00 – $6,720.00
The Market for Direct-to-Consumer (DTC) Laboratory Testing This Kalorama Information report provides reliable business intelligence on the growing Direct-to-Consumer (DTC) Testing market. The report details the companies that are providing this service and innovations that have recently occurred in the market. The report provides the trends driving growth, and stats influencing companies in the industry, the incidence of diseases in the U.S. and worldwide, demographics; life expectancy, and company strategies. Information is presented as a U.S market report. Specific information...Published: April 6, 2012 | Price: $3,995.00 – $7,990.00
This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living. Growth in the ambulatory aids market continues to be driven by several key trends including the aging U.S. population, new product introductions and relatively generous government reimbursement programs, despite recent modifications. As part of its market analysis, this report includes the following information: Current U.S. Market Size Estimates and Forecasts to 2016 Market Forecast to...Published: December 31, 2014 | Price: $1,995.00 – $3,990.00
The Market for Home Care Products Demand in the U.S. market for home care products and equipment continues to rise, with an aging population and an ongoing shift of chronic care patients from hospitals to home. New medical-technology devices are making it possible for the aging population and individuals with acute illnesses to remain at home and advances in treating acute diseases such as heart failure have transformed them into chronic diseases, allowing patients to live more productive lives at...Published: August 9, 2013 | Price: $3,995.00 – $7,990.00
This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. ...Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...Published: March 30, 2018 | Price: $3,995.00 – $7,990.00
What is The Market for Outsourced Manufacturing of IVD Products? Valued at more than $12 billion in 2017, the global OEM in vitro diagnostic (IVD) manufacturing segment is well positioned for long-term growth. Several trends and factors will boost the revenue potential of this business. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to expand product lines, broaden manufacturing capacity and capabilities, and serve selected customers. Contract IVD...Published: June 29, 2021 | Price: $4,000.00 – $8,000.00
Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities. This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,...Published: January 25, 2019 | Price: $5,000.00 – $10,000.00
The maturation of in vitro diagnostic (IVD) markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new, health-consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers. This report, The Market for In Vitro Diagnostic Tests in Latin America, focuses on the market for reagents and instruments in the major countries of the continent. The...Published: January 31, 2015 | Price: $1,995.00 – $3,990.00
The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier segment markets. Each country in Latin America is different in terms of their healthcare system, insurance services, laws and industry participants. For this reason, this...Published: October 13, 2017 | Price: $2,000.00 – $4,000.00
The Market for Inherited Disease Molecular Diagnostic Testing The detection of single nucleotide polymorphisms (SNPs) or gene variants from tissue, blood, urine and saliva samples can be used to diagnose inherited diseases and genetic disorders as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, but scientists believe others could predispose people to disease or...